abstract |
A method of inhibiting pro-inflammatory mediator release from basophils or mast cells to treat an inflammatory disease in a mammal, comprising administering to the mammal a therapeutically effective amount of one or more of the following proteins, RANTES, MIP-1α, MIP-1β, CTAP-III, or IP-10, or an analog of the proteins, or a peptide fragment of any one of these proteins or analogs. |